160
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Clinicopathologic and cytogenetic characterization of therapy-related acute T lymphoblastic leukemia in adult population

&
Pages 1460-1462 | Received 21 Jul 2015, Accepted 11 Aug 2015, Published online: 20 Nov 2015

References

  • Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
  • Leone G, Pagano L, Ben-Yehuda D, et al. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 2007;92:1389–1398.
  • Morton LM, Dores GM, Tucker MA, et al. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood 2013;121:2996.
  • Quesnel B, Kantarjian H, Bjergaard JP, et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993;11:2370–2379.
  • Super HJ, McCabe NR, Thirman MJ, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 1993;82:3705–3711.
  • Zhang L, Wang SA. A focused review of hematopoietic neoplasms occurring in the therapy-related setting. Int J Clin Exp Pathol 2014;7:3512–3523.
  • Liso V, Specchia G, Pannunzio A, et al. T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. Haematologica 1998;83:471–473.
  • Tsuboi K, Komatsu H, Miwa H, et al. T-cell acute lymphoblastic leukemia as a secondary leukemia after a 3-year remission of acute myelocytic leukemia. Int J Hematol 2003;77:518–521.
  • Bee PC, Gan GG, Sangkar JV, et al. A case of T-cell acute lymphoblastic leukemia after treatment of acute promyelocytic leukemia. Int J Hematol 2004;79:358–360.
  • Tazi I, Nafil H, Mahmal L, et al. A case of therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2) following treatment of breast cancer. Leuk Res 2011;35:e58.
  • Thomas DA, O'Brien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 2004;104:1624–1630.
  • Andersen MK, Christiansen DH, Jensen BA, et al. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 2001;114:539–543.
  • Lee SG, Choi JR, Kim JS, et al. Therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2): a case study and review of the literature. Cancer Genet Cytogenet 2009;191:51–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.